HBIOHARVARD BIOSCIENCE INC

Nasdaq harvardbioscience.com


$ 3.47 $ -0.06 (-1.7 %)    

Monday, 13-May-2024 11:21:52 EDT
QQQ $ 442.72 $ -0.69 (-0.16 %)
DIA $ 395.06 $ -1.32 (-0.33 %)
SPY $ 520.83 $ -1.76 (-0.34 %)
TLT $ 90.40 $ 0.07 (0.08 %)
GLD $ 215.88 $ -2.82 (-1.29 %)
$ 3.53
$ 3.53
$ 0.00 x 0
$ 3.47 x 200
$ 3.47 - $ 3.53
$ 3.44 - $ 6.20
69,177
na
153.21M
$ 1.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-07-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 04-26-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 03-11-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-12-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-18-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-16-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-08-2017 03-31-2017 10-Q
30 03-17-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 04-29-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-12-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 harvard-bioscience-continues-to-expect-2024-gross-margin-of-approximately-60-and-adjusted-ebitda-margin-in-the-mid-teens

For the full year 2024 revenues to be approximately flat versus 2023. Company sees second half growth versus both first half of...

 harvard-bioscience-q1-adj-002-inline-sales-2451m-miss-2579m-estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. This ...

 harvard-bioscience-q4-adj-eps-004-misses-005-estimate-sales-2815m-miss-2911m-estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of Adj $0.04 per share which missed the analyst consensus estimate...

 earnings-scheduled-for-march-7-2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

 harvard-bioscience-to-showcase-latest-solutions-for-preclinical-and-organoid-applications-at-society-of-toxicology-meeting

Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that it will be showcasing its latest product innovations at the Society...

 harvard-bioscience-q3-adjusted-eps-001-misses-004-estimate-sales-2536m-miss-2802m-estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of ...

 earnings-scheduled-for-november-7-2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

 harvard-bioscience-and-etisense-announce-agreement-for-supply-and-distribution-of-decro-miniature-telemetry-jacket-platform-for-pre-clinical-research

Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands...

 harvard-bioscience-expects-fy23-revenues-of-116m-120m-consensus-12076m

This expected growth anticipates an approximate 4 percentage point headwind from discontinued products.

 harvard-bioscience-q2-adj-eps-004-misses-005-estimate-sales-2880m-miss-2950m-estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly adj earnings of $0.04 per share which missed the analyst consensus estimate...

 earnings-scheduled-for-august-8-2023

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share o...

 benchmark-reiterates-speculative-buy-on-harvard-bioscience-maintains-7-price-target

Benchmark analyst Bruce Jackson reiterates Harvard Bioscience (NASDAQ:HBIO) with a Speculative Buy and maintains $7 price ta...

 harvard-bioscience-set-to-join-russell-2000-and-3000-indexes

Harvard Bioscience, Inc. (NASDAQ:HBIO) (the “Company”) today announced that it is set to join the Russell 2000® and Russell 300...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION